JANE STREET GROUP, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,244,232
+31.8%
97,817
+45.9%
0.00%
Q2 2023$943,684
+11.4%
67,023
+22.2%
0.00%
Q1 2023$847,479
+82.0%
54,853
+93.0%
0.00%
Q4 2022$465,770
-67.2%
28,418
-63.0%
0.00%
-100.0%
Q3 2022$1,422,000
+400.7%
76,863
+256.5%
0.00%
Q2 2022$284,000
-64.1%
21,560
-74.8%
0.00%
Q1 2022$792,000
-71.5%
85,425
-70.0%
0.00%
Q4 2021$2,780,000
+105.2%
284,563
+614.0%
0.00%
Q3 2021$1,355,000
+232.1%
39,853
+337.9%
0.00%
Q1 2021$408,000
-73.5%
9,100
-66.3%
0.00%
-100.0%
Q4 2020$1,542,000
+94.5%
26,999
+74.7%
0.00%
Q3 2020$793,000
-24.8%
15,457
-12.5%
0.00%
Q2 2020$1,055,000
+13.9%
17,671
+18.8%
0.00%
-100.0%
Q4 2019$926,000
+336.8%
14,872
+137.9%
0.00%
Q3 2019$212,000
-80.9%
6,252
-77.9%
0.00%
-100.0%
Q2 2018$1,112,00028,2640.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders